Clinical Trial Update: PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the pharmacokinetics of BV100 in patients with ventilator-associated pneumonia suspected or confirmed to be due to carbapenem-resistant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Acinetobacter Baumannii Infection
• Ventilator-associated Pneumonia

Drugs mentioned

• BV100

Snippet

Sponsor: BioVersys AG | Conditions: Ventilator Associated Pneumonia | Phase 2 | Status: COMPLETED